Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2017
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 TrialMarc P E André, Théodore Girinsky, Massimo Federico, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2021
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trialRachel Galot, Christophe Le Tourneau, Esma Saada-Bouzid, et al.
Clinical and Translational Radiation Oncology|January 26, 2024
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohortRenée Bultijnck, Mieke Van Hemelrijck, Valérie Fonteyne, et al.
Oral Oncology|July 27, 2019
Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancerEtienne Dauzier, Benjamin Lacas, Pierre Blanchard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 21, 2023
Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/10925Orit Kaidar-Person, Peggy Giasafaki, Liesbeth Boersma, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 2, 2024
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohortFilippo Alongi, Luca Nicosia, Umberto Ricardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2024
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare studySebastian M Christ, Filippo Alongi, Umberto Ricardi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2024
Stereotactic Body Radiotherapy for Centrally Located Inoperable Early-Stage NSCLC: EORTC 22113-08113 LungTech Phase II Trial ResultsAntonin Levy, Sonja Adebahr, Coen Hurkmans, et al.
The Lancet. Haematology|May 2, 2026
Very early [18F]FDG-PET-guided targeted therapy in untreated advanced-stage classic Hodgkin lymphoma (EORTC-1537-COBRA): primary results of a single-arm, multicentre, phase 2 trialMartin Hutchings, Arjan Diepstra, Anna Sureda Balari, et al.
CA: a Cancer Journal for Clinicians|May 16, 2026
Twenty-year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancerOrit Kaidar-Person, Caroline G Weltens, Catherine Fortpied, et al.
Pageof 5